NorthWest Biotherapeutics Inc (NWBO)

[XMaster2023]

The Journal Article indicates DCVax-L achieved Statistical Significance in rGBM and nGBM. First trial in over 2,000 or 27 years to do so. It is a monumental step forward and will be Approved in the UK within weeks as it was submitted in Dec 23.

Flaskworks 3.0 a closed manufacturing system will be approved within months because it will increase production by 10 while in a less expensive clean room environment.
Within 2 years Flaskworks 4.0 will increase production another 100%. Bringing the cost of treatment down yet again. Chemotherapy will be a thing of the past.
You’re the dreamer. This is science. It will advance as quickly as the computer chip.